Mirae Asset Global ETFs Holdings’s Emergent Biosolutions EBS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$254K	Buy	30,777 +1,334	+5%	+$13.8K	﹤0.01%	2226
2025 Q4	$363K	Sell	29,443 -760	-3%	-$8.14K	﹤0.01%	2049
2025 Q3	$267K	Sell	30,203 -3,155	-9%	-$24.5K	﹤0.01%	2167
2025 Q2	$213K	Buy	33,358 +28,185	+545%	+$161K	﹤0.01%	2252
2025 Q1	$24.1K	Sell	5,173 -554	-10%	-$4.59K	﹤0.01%	2962
2024 Q4	$53K	Buy	5,727 +57	+1%	+$523	﹤0.01%	2893
2024 Q3	$42.5K	Sell	5,670 -20,362	-78%	-$185K	﹤0.01%	2950
2024 Q2	$178K	Buy	+26,032	New	+$112K	﹤0.01%	2314

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Mirae Asset Global ETFs Holdings's EBS Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Emergent Biosolutions (EBS) stake by 4.5% in Q1 2026, buying an estimated $13.8K and bringing the position to 30,777 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #2226.

Mirae Asset Global ETFs Holdings first reported a position in EBS in Q2 2024 and has held it in 8 quarters since. The position peaked at $363K in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

Mirae Asset Global ETFs Holdings held 30,777 shares of Emergent Biosolutions worth $254K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 1,334 Emergent Biosolutions shares in Q1 2026, an estimated $13.8K.
Emergent Biosolutions made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2226 holding.
Mirae Asset Global ETFs Holdings first reported a position in Emergent Biosolutions in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Emergent Biosolutions position peaked at $363K in Q4 2025.
190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.